Study JR OÜ

12631183

General info

Name

Study JR OÜ

Registry code

12631183

VAT number

EE101718042

Type

OÜ - Limited Liability Company

Status

Registered

Foundation date

19.03.2014 (10)

Financial year

01.01-31.12

Capital

2 500.00 €

Activity

86221 - Provision of specialised medical treatment

Revenue

122 840 €

Profit

11 488 €

Profit margin

9%

Gross salary

-

Equity

185 307 €

Employees

1

Annual report

Submitted

Tax arrears

No tax arrears

Return on equity

6%

Return on assets

6%

Related parties

Owner Representative Beneficial owner Roles

Julia Reinmets

26.05.1974 (50)

100% - 2 500.00 EUR Board member Direct ownership

ABConsult Plus OÜ

11591790

- - - Founder

Financial info

2019
25.06.2020
2020
21.06.2021
2021
14.06.2022
2022
22.06.2023
2023
23.06.2024
Total Revenue 183 751 € 135 926 € 35 164 € 92 770 € 122 840 €
Net profit (loss) for the period 48 012 € 9 976 € -33 176 € 2 598 € 11 488 €
Profit Margin 26% 7% -94% 3% 9%
Current Assets 106 216 € 128 837 € 111 088 € 87 894 € 105 976 €
Fixed Assets 135 602 € 117 974 € 100 346 € 88 027 € 81 044 €
Total Assets 241 818 € 246 811 € 211 434 € 175 921 € 187 020 €
Current Liabilities 7 397 € 2 414 € 213 € 2 102 € 1 713 €
Non Current Liabilities - - - - -
Total Liabilities - - - - -
Share Capital - - - - -
Equity 234 421 € 244 397 € 211 221 € 173 819 € 185 307 €
Employees 6 5 1 1 1

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2024 Q1 31 147.54 € 7 419.29 € 691.3 € 6
2023 Q4 - 156.84 € 170.04 € 6
2023 Q3 - 379.2 € 411.12 € 6
2023 Q2 - 1 714.68 € 1 838.9 € 6
2023 Q1 - 1 699.37 € 1 790.3 € 29
2022 Q4 2 900 € 812 € 866.6 € 29
2022 Q3 - 11 139.68 € 1 214.45 € 29
2022 Q2 3 307.2 € 156.84 € 170.04 € 29
2022 Q1 457.01 € 187.34 € 170.04 € 29
2021 Q4 2 931 € 156.84 € 170.04 € 29
2021 Q3 7 837 € 156.84 € 170.04 € 29
2021 Q2 - 203.89 € 221.05 € 29
2021 Q1 16 804.09 € 2 172.08 € 2 315.5 € 29
2020 Q4 31 262.16 € 2 698.85 € 2 919.88 € 29
2020 Q3 15 817.83 € 158.04 € 165.24 € 29
2020 Q2 42 439.93 € 4 227.25 € 4 575.58 € 29
2020 Q1 77 484.88 € 4 654.2 € 4 459.16 € 29